ARS Pharmaceuticals, Inc. SPRY Other intangible assets—net
Other intangible assets—net at other companies
Other financials
Where this comes from
Reported directly by ARS Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about ARS Pharmaceuticals, Inc.'s other intangible assets—net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ARS Pharmaceuticals, Inc.'s other intangible assets—net?
- ARS Pharmaceuticals, Inc. (SPRY) reported other intangible assets—net of $14.18M in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s other intangible assets—net changed year-over-year?
- ARS Pharmaceuticals, Inc.'s other intangible assets—net increased by 95.8% year-over-year, from $7.24M to $14.18M.
- What does other intangible assets—net mean?
- This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.